Addition of Capecitabine in Breast Cancer First-line Chemotherapy Improves Survival of Breast Cancer Patients

Objective: Capecitabine is an antimetabolic fluoropyrimidine deoxynucleoside carbamate drug that can be converted to 5-FU in vivo. Currently, the role of capecitabine in the treatment of advanced breast cancer has been recognized. Also, Several meta-analyses have elucidated the role of capecitabine...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Di, Chen, Xiu, Li, Xingjiang, Mao, Zhixiang, Tang, Wenjuan, Zhang, Wei, Ding, Li, Tang, Jinhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360291/
https://www.ncbi.nlm.nih.gov/pubmed/30719136
http://dx.doi.org/10.7150/jca.29739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360291/
https://www.ncbi.nlm.nih.gov/pubmed/30719136
http://dx.doi.org/10.7150/jca.29739

Ejemplares similares